Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jul 10:8:442.
doi: 10.3332/ecancer.2014.442. eCollection 2014.

The Repurposing Drugs in Oncology (ReDO) Project

Pan Pantziarka  1 , Gauthier Bouche  2 , Lydie Meheus  2 , Vidula Sukhatme  3 , Vikas P Sukhatme  3 , P Vikas  4
Affiliations

The Repurposing Drugs in Oncology (ReDO) Project

Pan Pantziarka et al. Ecancermedicalscience. .

Abstract

The Repurposing Drugs in Oncology (ReDO) Project seeks to repurpose well-known and well-characterised non-cancer drugs for new uses in oncology. The rationale for this project is presented, examining current issues in oncological drug development, challenges for health systems, and existing and future patient needs. In addition to discussing the advantages of repurposing, the paper also outlines some of the characteristics used in the selection of drug candidates by this project. Challenges in moving candidate drugs into clinical trial and subsequent practice are also discussed.

Keywords: ReDO Project; drug development; drug repurposing; health economics; health policy; metronomics.

PubMed Disclaimer

References

    1. Scannell JW, et al. Diagnosing the decline in pharmaceutical R&D efficiency. Nat Rev Drug Discov. 11(3):191–200. - PubMed
    1. Pammolli F, Magazzini L, Riccaboni M. The productivity crisis in pharmaceutical R&D. Nat Rev Drug Discov. 2011;10(6):428–38. doi: 10.1038/nrd3405. - DOI - PubMed
    1. Elebring T, Gill A, Plowright AT. What is the most important approach in current drug discovery: doing the right things or doing things right? Drug Discov Today. 2012;17(21–22):1166–9. doi: 10.1016/j.drudis.2012.04.009. - DOI - PubMed
    1. Paul SM, et al. How to improve R&D productivity: the pharmaceutical industry’s grand challenge. Nat Rev Drug Discov. 2010;9(3):203–14. - PubMed
    1. Hay M, et al. Clinical development success rates for investigational drugs. Nat Biotechnol. 2014;32(1):40–51. doi: 10.1038/nbt.2786. - DOI - PubMed

LinkOut - more resources